CytoMed Therapeutics Limited
GDTC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,843 | -$3,132 | -$2,338 | -$1,521 |
| Dep. & Amort. | $246 | $289 | $293 | $245 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$58 | -$4 | -$108 | -$321 |
| Other Non-Cash | -$39 | $256 | $1,048 | $328 |
| Operating Cash Flow | -$1,984 | -$2,676 | -$1,044 | -$1,270 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,025 | -$44 | -$354 | -$432 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$2,063 | $0 | -$180 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $1,520 | $1 | $0 | $1 |
| Investing Cash Flow | $495 | -$2,106 | -$353 | -$611 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$33 | -$31 | -$59 | -$44 |
| Stock Issued | $0 | $8,418 | $1,104 | $2,976 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | -$223 | -$252 | $162 |
| Financing Cash Flow | -$33 | $8,165 | $793 | $3,094 |
| Forex Effect | -$42 | $73 | -$30 | -$24 |
| Net Chg. in Cash | -$1,277 | $3,537 | -$684 | $1,193 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,717 | $1,179 | $1,863 | $670 |
| End Cash | $3,439 | $4,717 | $1,179 | $1,863 |
| Free Cash Flow | -$3,010 | -$2,720 | -$1,398 | -$1,702 |